← back to search

Siddique Abbasi

Amgen (United States) · US
Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Cardiovascular Function and Risk Factors, Cardiac Imaging and Diagnostics, Cardiovascular Disease and Adiposity, and Heart Failure Treatment and Management.
h-index
40
citations
5,383
works
127
NIH funding
primary concept
Medicine
email

Recent publications

Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial
European Heart Journal 2022cited by 35position: middledoi
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure
JAMA Cardiology 2021cited by 104position: middledoi
Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF
Journal of the American College of Cardiology 2021cited by 102position: middledoi
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
New England Journal of Medicine 2020cited by 637position: middledoi
Omecamtiv Mecarbil in Chronic Heart Failure with Reduced Ejection Fraction: GALACTIC-HF Baseline Characteristics and Comparison with Contemporary Clinical Trials
European Journal of Heart Failure 2020cited by 64position: middledoi
Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy
Journal of Cardiovascular Magnetic Resonance 2016cited by 51position: middledoi
Transitions in Metabolic Risk and Long‐Term Cardiovascular Health: Coronary Artery Risk Development in Young Adults (CARDIA) Study
Journal of the American Heart Association 2016cited by 48position: middledoi
Association of Fitness in Young Adulthood With Survival and Cardiovascular Risk
JAMA Internal Medicine 2015cited by 155position: middledoi
Visceral adiposity and left ventricular remodeling: The Multi-Ethnic Study of Atherosclerosis
Nutrition Metabolism and Cardiovascular Diseases 2015cited by 67position: firstdoi
Visceral Adiposity and the Risk of Metabolic Syndrome Across Body Mass Index
JACC. Cardiovascular imaging 2014cited by 408position: middledoi
Diltiazem Treatment for Pre-Clinical Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers
JACC Heart Failure 2014cited by 158position: middledoi
Effect of Sleep Apnea and Continuous Positive Airway Pressure on Cardiac Structure and Recurrence of Atrial Fibrillation
Journal of the American Heart Association 2013cited by 157position: middledoi
Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients
Journal of Cardiovascular Magnetic Resonance 2013cited by 87position: firstdoi
Hydroxychloroquine: A Treatable Cause of Cardiomyopathy
Journal of the American College of Cardiology 2012cited by 23position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Ravi V. Shah · University College London6 papers (2013–2016)Michael Jerosch‐Herold · Harvard University6 papers (2013–2016)Raymond Y. Kwong · Broad Institute4 papers (2013–2014)Venkatesh L. Murthy · Michigan United4 papers (2014–2016)João A.C. Lima · University of Birmingham4 papers (2014–2016)Brian Claggett · Harvard University3 papers (2021–2022)Stephen B. Heitner · Brigham and Women's Hospital3 papers (2021–2022)Ron Blankstein · Harvard University3 papers (2013–2015)John R. Teerlink · University of Glasgow3 papers (2021–2022)G. Michael Felker · Duke University3 papers (2021–2022)John J.V. McMurray · University of Glasgow3 papers (2021–2022)Marco Metra · Mylan (South Africa)3 papers (2021–2022)Scott D. Solomon · Harvard University3 papers (2021–2022)Fady I. Malik · Jena University Hospital3 papers (2021–2022)Stuart Kupfer · Brigham and Women's Hospital3 papers (2021–2022)Tomas G. Neilan · Harvard University2 papers (2013–2015)Rafael Díaz · Instituto Cardiovascular de Rosario2 papers (2021–2021)Steven D. Colan · University of Utah2 papers (2014–2016)Jonathan G. Howlett · Calgary Laboratory Services2 papers (2021–2022)Carolyn Y. Ho · Brigham and Women's Hospital2 papers (2014–2016)